跳至主要内容
临床试验/NL-OMON47274
NL-OMON47274已完成不适用

Dopaminergic Functioning in Autism Spectrum Disorder - Dopaminergic Functioning in Autism Spectrum Disorder

Stichting Rivierduinen0 个研究点目标入组 69 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
69

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. DSM-5 diagnosis of Autism Spectrum Disorder (Patients only, for controls this is an exclusion criterion, see below).
  • 2. Age: 18-30 years.

排除标准

  • 1. DSM-5 diagnosis of Autism Spectrum Disorder (Healthy controls only)
  • 2. Autism Spectrum Disorder due to a known organic disorder (*Syndromal ASD*, e.g., due to Fragile X syndrome, Klinefelter syndrome, 22q11 deletion syndrome).
  • 3. Neurological disorder (e.g., epilepsy) or evidence of brain damage.
  • 4. History of meningitis.
  • 5. Intellectual disability (IQ<85).
  • 6. Non-affective Psychotic Disorder or Bipolar Disorder (DSM-5: 297.1, 298.8, 295.40, 295.90, 295.70, 292.9, 291.9, 293.81, 293.82, 293.89, 298.9, 296.89, 303.13, 293.83, 296.89, 296.80, 296.4x, 296.5x, 296.7).
  • 7. Social exclusion due to other causes than ASD: visible ethnic minority status, serious physical disability, serious visual or hearing impairment; at discretion of the researcher.
  • 8. Current use of drugs (XTC, cocaine, etc.). Use of cannabis is allowed, but should have been stopped at least one month before the study. Cannabis abuse earlier in life is not allowed.
  • 9. Alcohol- or drug abuse or dependence (DSM-5).
  • 10. Use of an antipsychotic (ever) if prescribed for a psychotic disorder, as a former psychotic disorder is an exclusion criterion. Occasionally, antipsychotics are prescribed against e.g. anxiety or aggression. In these cases:
  • a) Incidental former use of antipsychotic is allowed, if last use has been more than a year ago.
  • b) Regular former use of antipsychotic is allowed, if last use has been more than two years ago.
  • c) Antipsychotic formerly administered as depot medication is allowed, if last injection has been more than two years ago.
  • 11. Use of the antipsychotic quetiapine (ever), if prescribed in relation to a psychotic disorder. However, quetiapine is often prescribed against sleep difficulties and has a low affinity to dopamine receptors. In these cases:
  • a) Consumption is allowed if previously consumed in a low dose (*50mg), but last use has been more than 3 months ago.
  • b) Consumption is allowed if previously consumed in a high dose (>50mg), but last use has been more than 6 months ago.
  • 12. Current use of ADHD medication (e.g. methylphenidate). Individuals who have stopped using these drugs for at least one year can participate in the study.
  • 13. Current use of benzodiazepine or promethazine, unless last use has been more than 1 month ago.
  • 14. Current use of other psychotropic drugs. Individuals who have stopped using the drugs for at least 3 months can participate in the study.
  • 15. Smoking during the period of three hours prior to the PET/CT scan and eating or using caffeinated drinks during the period of six hours prior to the PET/CT-scan.
  • 16. Participation in a scientific examination where radiation was used, in the last year.
  • 17. Positive urine drug screen on the day of the PET/CT scan. Participants will be tested on cannabis, amphetamine, XTC, cocaine and opiates.
  • 18. In women: positive pregnancy test on the day of the PET/CT scan and lactation.
  • 19. Metal objects in or around the body.

研究者

发起方
Stichting Rivierduinen

相似试验